Pfizer Halts Sales of Exubera In Wake of Lung Cancer Fears
In wake of news that its inhaled insulin product Exubera has been linked to lung cancer, Pfizer Inc. has announced that it will cease manufacturing the drug and update labels on the remaining product to carry a cancer warning.
This entry was posted on Wednesday, April 16th, 2008 at 1:25 pm and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.